BOYLE EUGENE 4
4 · SAMARITAN PHARMACEUTICALS INC · Filed Sep 15, 2008
Insider Transaction Report
Form 4
BOYLE EUGENE
DirectorChief Financial Officer
Transactions
- Award
Common Stock
2008-09-11$0.20/sh+435,000$86,130→ 435,000 total(indirect: Evergreen LifeSciences DB Plan) - Disposition to Issuer
Common Stock
2008-09-11$0.20/sh−435,000$86,130→ 674,207 total(indirect: Evergreen LifeSciences, Inc.)